Editorial: a new shift in the paradigm of treatment for the irritable bowel syndrome?

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|41|12|1296-1296

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.12, 2015-06, pp. : 1296-1296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: fibre and FODMAPs in constipation and irritable bowel syndrome

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 3, 2015-08 ,pp. : 383-384

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tegaserod in the treatment of irritable bowel syndrome with constipation

By Saad Richard   Chey William D  

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 29-42

Future Medicine

Access to resources Recommend Favorite

New treatments for irritable bowel syndrome in women

By Adeyemo Mopelola A   Chang Lin  

Women's Health, Vol. 4, Iss. 6, 2008-11 ,pp. : 605-623

Future Medicine

Access to resources Recommend Favorite

Editorial: gut‐directed hypnotherapy or low FODMAP diet for the treatment of irritable bowel syndrome?

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 44, Iss. 8, 2016-10 ,pp. : 901-902

John Wiley & Sons Inc

Access to resources Recommend Favorite

Irritable bowel syndrome and somatization

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 5, 2015-05 ,pp. : 740-740

John Wiley & Sons Inc

Access to resources Recommend Favorite